Low-dose Aspirin Therapy for Esophageal Cancer
NCT02326779
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
The study could not be performed.
Conditions
Esophageal Cancer
Interventions
DRUG:
Acetylsalicylic acid
Sponsor
Zhejiang University